These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 31538382)

  • 21. Ethical implications and practical considerations of ethnically targeted screening for genetic disorders: the case of hemoglobinopathy screening.
    Hinton CF; Grant AM; Grosse SD
    Ethn Health; 2011; 16(4-5):377-88. PubMed ID: 21797724
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic screening in reproductive health care.
    Mennuti MT
    Clin Obstet Gynecol; 2008 Mar; 51(1):3-23. PubMed ID: 18303496
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prenatal and preconception population carrier screening for cystic fibrosis in Australia: where are we up to?
    Massie J; Ioannou L; Delatycki M
    Aust N Z J Obstet Gynaecol; 2014 Dec; 54(6):503-9. PubMed ID: 25350764
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prenatal and newborn screening for hemoglobinopathies.
    Hoppe CC
    Int J Lab Hematol; 2013 Jun; 35(3):297-305. PubMed ID: 23590658
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cystic fibrosis prenatal screening in genetic counseling practice: recommendations of the National Society of Genetic Counselors.
    Langfelder-Schwind E; Kloza E; Sugarman E; Pettersen B; Brown T; Jensen K; Marcus S; Redman J;
    J Genet Couns; 2005 Feb; 14(1):1-15. PubMed ID: 15789152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cystic fibrosis.
    Shulman LP; Elias S
    Clin Perinatol; 2001 Jun; 28(2):383-93. PubMed ID: 11499059
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Population screening for reproductive risk for single gene disorders in Australia: now and the future.
    Delatycki MB
    Twin Res Hum Genet; 2008 Aug; 11(4):422-30. PubMed ID: 18637742
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carrier screening for cystic fibrosis: a perinatal perspective.
    Demsey SA
    J Perinat Neonatal Nurs; 1999 Sep; 13(2):14-26. PubMed ID: 10818851
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Updates in Genetic Screening for the General Obstetrician.
    Dunn TM; Subramaniam A
    Obstet Gynecol Clin North Am; 2023 Sep; 50(3):493-507. PubMed ID: 37500212
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Large-scale population-based genetic screening and prenatal diagnosis for thalassemias in Zhuhai City of Guangdong Province].
    Zhou YQ; Shang X; Yin BM; Xiong F; Xiao QZ; Zhou WJ; Zhang YL; Xu XM
    Zhonghua Fu Chan Ke Za Zhi; 2012 Feb; 47(2):90-5. PubMed ID: 22455738
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Implementation of cell-free DNA-based non-invasive prenatal testing in a National Health Service Regional Genetics Laboratory.
    Togneri FS; Kilby MD; Young E; Court S; Williams D; Griffiths MJ; Allen SK
    Genet Res (Camb); 2019 Dec; 101():e11. PubMed ID: 31813398
    [TBL] [Abstract][Full Text] [Related]  

  • 32. International perspectives on the implementation of reproductive carrier screening.
    Delatycki MB; Alkuraya F; Archibald A; Castellani C; Cornel M; Grody WW; Henneman L; Ioannides AS; Kirk E; Laing N; Lucassen A; Massie J; Schuurmans J; Thong MK; van Langen I; Zlotogora J
    Prenat Diagn; 2020 Feb; 40(3):301-310. PubMed ID: 31774570
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prenatal Diagnosis Procedures and Techniques to Obtain a Diagnostic Fetal Specimen or Tissue: Maternal and Fetal Risks and Benefits.
    Wilson RD; Gagnon A; Audibert F; Campagnolo C; Carroll J;
    J Obstet Gynaecol Can; 2015 Jul; 37(7):656-668. PubMed ID: 26366824
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention and control of thalassemia at Saraburi Regional Hospital.
    Chareonkul P; Kraisin J
    J Med Assoc Thai; 2004 Jan; 87(1):8-15. PubMed ID: 14971529
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cystic fibrosis carrier screening practices in an ethnically diverse region: experience of the Genetic Network of the Empire State, Puerto Rico, and the U.S. Virgin Islands.
    Schwind EL; Wolfe M; Greendale K; Misra LM; Pass KA; Wallerstein R
    Genet Test; 1999; 3(2):215-8. PubMed ID: 10464670
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SMFM Statement: clarification of recommendations regarding cell-free DNA aneuploidy screening.
    Society for Maternal-Fetal Medicine (SMFM) Publications Committee. Electronic address: esteele@smfm.org
    Am J Obstet Gynecol; 2015 Dec; 213(6):753-4. PubMed ID: 26458766
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic screening for cystic fibrosis.
    Gregg AR; Simpson JL
    Obstet Gynecol Clin North Am; 2002 Jun; 29(2):329-40. PubMed ID: 12108832
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Attitudes towards non-invasive prenatal testing for aneuploidy among US adults of reproductive age.
    Allyse M; Sayres LC; Goodspeed TA; Cho MK
    J Perinatol; 2014 Jun; 34(6):429-34. PubMed ID: 24603453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current genetic counseling practice in the United States following positive non-invasive prenatal testing for sex chromosome abnormalities.
    Fleddermann L; Hashmi SS; Stevens B; Murphy L; Rodriguez-Buritica D; Friel LA; Singletary C
    J Genet Couns; 2019 Aug; 28(4):802-811. PubMed ID: 30946507
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spinal Muscular Atrophy: Inheritance, Screening, and Counseling for the Obstetric Provider.
    Hopkins MK; Dugoff L; Kuller JA
    Obstet Gynecol Surv; 2021 Mar; 76(3):166-169. PubMed ID: 33783545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.